ALX Oncology Holdings Inc (ALXO) Earning Prediction
ALX Oncology Holdings Inc (ALXO) is set to release its earnings performance on 03/09 08:15:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of -0.38 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
ALXO Transcript
The company's strategic focus on biomarker-driven approaches and strong clinical trial results in HER2-positive cancers indicate promising developments. The extension of the cash runway into 2027 and the Sanofi collaboration further enhance the outlook. Despite some uncertainties in execution and supply chain risks, the positive clinical data and strategic partnerships suggest a positive market reaction.
The earnings call summary reflects strong financial performance with extended cash runway, improved response rates, and significant market opportunities. The Q&A section highlights positive sentiment from investigators and a clear path forward without FDA delays. Despite some management ambiguities, the overall outlook remains optimistic, bolstered by promising trial results and substantial market potential. These factors suggest a positive stock price movement over the next two weeks.
ALXO Slides
ALXO Report
Frequently Asked Questions
What is the ALX Oncology Holdings Inc Earnings Release Date and Time?
ALX Oncology Holdings Inc (ALXO) is scheduled to release its earnings report onMar 9, 2026, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for ALX Oncology Holdings Inc Revenue and EPS?
Analysts' consensus predicts in revenue and an EPS of -0.38 for ALX Oncology Holdings Inc's .
What Does Intellectia's AI Predict for ALX Oncology Holdings Inc Earnings?
Intellectia's exclusive AI algorithms forecast a forALX Oncology Holdings Inc's earnings, with a prediction date of Mar 9, 2026. ALX Oncology Holdings Inc
How Can I Use This Earnings Prediction to Trade ALXO Stock?
Leverage Intellectia's AI forecast to position trades ahead of theMar 9, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like ALX Oncology Holdings Inc ?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
